CorNeat Vision
CorNeat Vision is dedicated to developing innovative biomimetic medical solutions aimed at addressing unmet medical needs across various therapeutic fields. Their mission is to harness biomimicry to improve health and equality worldwide, focusing on creating permanent, synthetic implants that integrate seamlessly with human tissue.
Industries
Nr. of Employees
small (1-50)
Awards
CorNeat gPatch: A novel approach to gingival guided tissue and bone regeneration (GTR, GBR) using EverMatrix™ technology
Funding (ceiling)
$2,240,535
Award Year
2022
Military Prototype Advancement Initiative (MPAI)
CorNeat KPro: A synthetic self-integrating artificial cornea: Accelerating FDA clearance for combat related corneal blindness indications
Funding (ceiling)
$2,192,848.46
Award Year
2023
Patents
Keratoprosthesis devices and kits and surgical methods of their use
2025-07-22 • US-12364591-B2
View Details
Keratoprosthesis devices and kits and surgical methods of their use
2025-07-22 • US-12364591-B2
View DetailsProducts
Artificial cornea (synthetic keratoprosthesis)
A biomimetic, fully synthetic corneal implant engineered to integrate permanently with the eye wall and restore optical function without donor tissue.
Synthetic scleral reinforcement patch (non-degradable)
Thin, sterile, non-degradable synthetic tissue patch intended to reinforce the sclera and reconstruct the ocular surface as an alternative to tissue grafts.
Glaucoma drainage device for refractory cases
A drainage implant intended to extend minimally invasive glaucoma surgery options for severe or refractory patients, designed to be concealed beneath tissue and integrated with surrounding structures.
Artificial cornea (synthetic keratoprosthesis)
A biomimetic, fully synthetic corneal implant engineered to integrate permanently with the eye wall and restore optical function without donor tissue.
Synthetic scleral reinforcement patch (non-degradable)
Thin, sterile, non-degradable synthetic tissue patch intended to reinforce the sclera and reconstruct the ocular surface as an alternative to tissue grafts.
Glaucoma drainage device for refractory cases
A drainage implant intended to extend minimally invasive glaucoma surgery options for severe or refractory patients, designed to be concealed beneath tissue and integrated with surrounding structures.
Expertise Areas
- Biomaterials and tissue integration
- Ophthalmic implant design and development
- Preclinical safety and biocompatibility testing
- First-in-human clinical trial execution
Key Technologies
- Tissue-integrating synthetic biomaterials (non-degradable polymer matrices)
- Synthetic keratoprosthesis (artificial cornea)
- Synthetic scleral reinforcement membranes
- Glaucoma drainage device design
Key People
News & Updates
Come and visit our booth at the American Glaucoma Society's annual meeting.
Our synthetic cornea, the CorNeat KPro, is featured in the Corneal Physician magazine!
A profile on our CEO and VP R&D, Almog Aley-Raz.
The CorNeat EverPatch, our synthetic tissue patch, hits the newsstands!
The CorNeat EverPatch received FDA 510(k) clearance in June 2023, marking a significant milestone for the product.
The CorNeat KPro successfully completed its First-in-Human trial, allowing corneally blind patients to regain their sight and independence.
Come and visit our booth at the American Glaucoma Society's annual meeting.
Our synthetic cornea, the CorNeat KPro, is featured in the Corneal Physician magazine!
A profile on our CEO and VP R&D, Almog Aley-Raz.
The CorNeat EverPatch, our synthetic tissue patch, hits the newsstands!
The CorNeat EverPatch received FDA 510(k) clearance in June 2023, marking a significant milestone for the product.
The CorNeat KPro successfully completed its First-in-Human trial, allowing corneally blind patients to regain their sight and independence.